Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Interventional Post-Authorisation Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines

NCT05481931 is registered in ClinicalTrials.gov with Evolus, Inc. as lead sponsor.

NCT NCT05481931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05481931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Interventional Post-Authorisation Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines
Lead sponsor
Evolus, Inc.
Phase
Observational
Overall status
Completed
Start date
March 15, 2023
Completion date
April 13, 2026
Enrollment
756 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glabellar frown lines